Advanced search
Publication Cover
Clinical Ophthalmology Volume 15, 2021 - Issue
Submit an article Journal homepage
112
Views
6
CrossRef citations to date
0
Altmetric
Original Research

Dexamethasone Sustained-Release Intracanalicular Insert for Control of Postoperative Inflammation After Pars Plana Vitrectomy

Ivan J SuñerRetina Associates of Florida, Tampa, FL, USACorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0003-0123-846XView further author information
ORCID Icon &
Marc C PedenRetina Associates of Florida, Tampa, FL, USAView further author information
Pages 3859-3864 | Published online: 17 Sep 2021

References

  • Machemer R, Benson WE. Vitrectomy: A Pars Plana Approach. Grune & Stratton; 1975.
  • Fujii GY, De Juan E, Humayun MS, et al. A new 25-gauge instrument system for transconjunctival sutureless vitrectomy surgery. Ophthalmology. 2002;109(10):1807–1812. doi:10.1016/s0161-6420(02)01179-x
  • Oshima Y, Wakabayashi T, Sato T, Ohji M, Tano Y. A 27-gauge instrument system for transconjunctival sutureless microincision vitrectomy surgery. Ophthalmology. 2010;117(1):93–102.e2. doi:10.1016/j.ophtha.2009.06.043
  • Inoue Y, Kadonosono K, Yamakawa T, et al. Surgically-induced inflammation with 20-, 23-, and 25-gauge vitrectomy systems: an experimental study. Retina Phila Pa. 2009;29(4):477–480. doi:10.1097/IAE.0b013e31819a6004
  • An JA, Kasner O, Samek DA, Lévesque V. Evaluation of eyedrop administration by inexperienced patients after cataract surgery. J Cataract Refract Surg. 2014;40(11):1857–1861. doi:10.1016/j.jcrs.2014.02.037
  • Hennessy AL, Katz J, Covert D, et al. A video study of drop instillation in both glaucoma and retina patients with visual impairment. Am J Ophthalmol. 2011;152(6):982–988. doi:10.1016/j.ajo.2011.05.015
  • Hermann MM, Ustündag C, Diestelhorst M. Electronic compliance monitoring of topical treatment after ophthalmic surgery. Int Ophthalmol. 2010;30(4):385–390. doi:10.1007/s10792-010-9362-3
  • Newman-Casey PA, Robin AL, Blachley T, et al. The most common barriers to glaucoma medication adherence: a cross-sectional survey. Ophthalmology. 2015;122(7):1308–1316. doi:10.1016/j.ophtha.2015.03.026
  • Walters T, Bafna S. Efficacy and safety of sustained release dexamethasone for the treatment of ocular pain and inflammation after cataract surgery: results from two phase 3 studies. J Clin Exp Ophthalmol. 2016;7(4):1–11. doi:10.4172/2155-9570.1000572
  • Tyson SL, Bafna S, Gira JP, et al. Multicenter randomized phase 3 study of a sustained-release intracanalicular dexamethasone insert for treatment of ocular inflammation and pain after cataract surgery. J Cataract Refract Surg. 2019;45(2):204–212. doi:10.1016/j.jcrs.2018.09.023
  • Kim SY, Shin JA, Yum HR, Han H, Yang JW, Park YH. Long-term trends in intraocular pressure after combined vitrectomy with sub-tenon injection of triamcinolone acetonide. Retina. 2015;35(3):564–569. doi:10.1097/IAE.0000000000000333
  • Lai CC, Wang NK, Wu WC, et al. The long-term anatomical and visual effect of intravitreal triamcinolone injection during vitrectomy for the treatment of idiopathic macular epiretinal membrane. Cutan Ocul Toxicol. 2011;30(4):292–297. doi:10.3109/15569527.2011.568031
  • Zheng A, Chin EK, Almeida DR, et al. Combined vitrectomy and intravitreal dexamethasone (ozurdex) sustained-release implant. Retina. 2016;36:2087. doi:10.1097/IAE.0000000000001063
  • Sisk RA, Patel YP, Foster RE, Petersen MR. Erosive retinopathy and retinal detachment from depot Intravitreal triamcinolone acetonide injection at the end of pars plana vitrectomy. Ophthalmic Surg Lasers Imaging Retina. 2019;50(10):613–619. doi:10.3928/23258160-20191009-03
  • Rahimy E, Khurana RN. Anterior segment migration of dexamethasone implant: risk factors, complications, and management. Curr Opin Ophthalmol. 2017;28(3):246–251. doi:10.1097/ICU.0000000000000365
  • Grzybowski A, Brockmann T, Kanclerz P, Pleyer U. Dexamethasone intraocular suspension: a long-acting therapeutic for treating inflammation associated with cataract surgery. J Ocul Pharmacol Ther. 2019;35(10):525–534. doi:10.1089/jop.2019.0072
  • Donnenfeld E, Holland E. Dexamethasone intracameral drug-delivery suspension for inflammation associated with cataract surgery: a randomized, placebo-controlled, Phase III trial. Ophthalmology. 2018;125(6):799–806. doi:10.1016/j.ophtha.2017.12.029
  • Lindstrom RL, Galloway MS, Grzybowski A, Liegner JT. Dropless cataract surgery: an overview. Curr Pharm Des. 2017;23(4):558–564. doi:10.2174/1381612822666161129150628
  • Gira JP, Sampson R, Silverstein SM, Walters TR, Metzinger JL, Talamo JH. Evaluating the patient experience after implantation of a 0.4 mg sustained release dexamethasone intracanalicular insert (DextenzaTM): results of a qualitative survey. Patient Prefer Adherence. 2017;11:487–494. doi:10.2147/PPA.S126283

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.